Osiris Therapeutics Inc. (NASDAQ:OSIR)’s share price was up 4.1% on Thursday . The stock traded as high as $5.35 and last traded at $5.28, with a volume of 58,053 shares changing hands. The stock had previously closed at $5.07.

The company has a market capitalization of $182.25 million and a PE ratio of 125.95. The firm’s 50-day moving average is $5.14 and its 200 day moving average is $5.69.

An institutional investor recently raised its position in Osiris Therapeutics stock. GSA Capital Partners LLP raised its position in shares of Osiris Therapeutics Inc. (NASDAQ:OSIR) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 98,901 shares of the company’s stock after buying an additional 9,702 shares during the period. GSA Capital Partners LLP owned about 0.29% of Osiris Therapeutics worth $1,027,000 as of its most recent filing with the SEC.

Osiris Therapeutics, Inc is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company’s offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and Grafix.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.